Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Payables (2020 - 2025)

Historic Payables for Mainz Biomed (MYNZ) over the last 5 years, with Q4 2024 value amounting to $2.3 million.

  • Mainz Biomed's Payables fell 2792.77% to $2.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.3 million, marking a year-over-year decrease of 2792.77%. This contributed to the annual value of $2.3 million for FY2024, which is 2792.77% down from last year.
  • As of Q4 2024, Mainz Biomed's Payables stood at $2.3 million, which was down 2792.77% from $3.2 million recorded in Q4 2023.
  • Mainz Biomed's 5-year Payables high stood at $3.2 million for Q4 2023, and its period low was $423664.0 during Q4 2020.
  • For the 5-year period, Mainz Biomed's Payables averaged around $1.9 million, with its median value being $2.3 million (2024).
  • Its Payables has fluctuated over the past 5 years, first skyrocketed by 23648.72% in 2022, then crashed by 2792.77% in 2024.
  • Quarter analysis of 5 years shows Mainz Biomed's Payables stood at $423664.0 in 2020, then skyrocketed by 90.61% to $807540.0 in 2021, then soared by 236.49% to $2.7 million in 2022, then rose by 17.19% to $3.2 million in 2023, then dropped by 27.93% to $2.3 million in 2024.
  • Its Payables stands at $2.3 million for Q4 2024, versus $3.2 million for Q4 2023 and $2.7 million for Q4 2022.